Previous studies reported that ghrelin levels in obese, insulin-resistant, or metabolic syndrome patients were reduced (35, 36, 37), and such reduction of ghrelin contributed to the development of T2D (38, 39). This evidence concerns the gene GHRL and type 2 diabetes mellitus.